Stocktoria
Anixa Biosciences Inc ANIX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1983-10-07
Anixa Biosciences Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | -6586.2% | -5243.3% | — | -2565.6% | — | -4756.0% | -1284.4% | -1676.0% | -1503.0% |
| Net margin | — | -5978.1% | -4671.9% | — | -2530.1% | — | -4658.8% | -1258.1% | -1381.8% | -1672.1% |
| FCF margin | — | — | — | — | — | — | -1966.8% | -387.6% | -1055.7% | -1176.1% |
| Return on assets | -68.0% | -58.1% | -38.4% | -44.7% | -35.7% | -106.0% | -185.1% | -217.0% | -56.8% | -89.1% |
| Return on equity | -72.1% | -62.8% | -40.3% | -46.8% | -36.6% | -114.3% | -222.5% | -257.5% | -63.2% | -508.0% |
| Current ratio | 8.08 | 8.54 | 12.50 | 14.83 | 28.35 | 7.88 | 4.11 | 4.38 | 7.89 | 7.25 |
Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.